Isotopically enriched arylsulfonamide CCR3 antagonists

Details for Australian Patent Application No. 2011223873 (hide)

Owner Axikin Pharmaceuticals, Inc.

Inventors Ly, Tai Wei; Potter, Garrett Thomas

Agent HENRY HUGHES LTD

Pub. Number AU-A-2011223873

PCT Pub. Number WO2011/109345

Priority 61/309,815 02.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

C07D 295/26 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/135 - having aromatic rings, e.g. methadone

A61P 11/06 Drugs for disorders of the respiratory system

C07B 59/00 Introduction of isotopes of elements into organic compounds

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/109345 Priority application(s): WO2011/109345

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223878-Devices for dispensing and displaying products and package assemblies for use with the same

2011223866-Methods and compositions for treating Degos' disease